.

Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Chinese Patent Office
Cipla
Teva
Merck
McKesson
McKinsey
Argus Health
Express Scripts
US Army

Generated: January 16, 2018

DrugPatentWatch Database Preview

US Patents With Foreign Priority to Japan Patent: 2000-265414

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
CelgeneISTODAXromidepsinPOWDER;IV (INFUSION)022393-001Nov 5, 2009RXYesYes➤ Subscribe➤ SubscribeY
CelgeneISTODAXromidepsinPOWDER;IV (INFUSION)022393-001Nov 5, 2009RXYesYes➤ Subscribe➤ SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist